about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverMarburgvirus genomics and association with a large hemorrhagic fever outbreak in AngolaInflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat ModelEbola and marburg hemorrhagic fever.Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationReverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.Curcumin inhibits Rift Valley fever virus replication in human cells.Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virusAerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.Animal models of Rift Valley fever virus infection.Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies.Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007.Development of novel mechanisms for housing, handling, and remote monitoring of common marmosets at animal biosafety level 3.A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley Fever encephalitis.The Efficacy of the Interferon Alpha/Beta Response versus Arboviruses Is Temperature Dependent.Curcumin inhibits Rift Valley fever virus replication in human cellsNeutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in ratsA Vibrating Mesh Nebulizer as an Alternative to the Collison Three-Jet Nebulizer for Infectious Disease Aerobiology
P50
Q21092271-1E9AD13B-78CF-4202-B6F5-14C973DA77B2Q24548936-D6FDC4FC-B24A-49A8-A22B-5CCF32ABBB87Q33429285-FC78F702-4E67-486F-B02E-012BC79C1649Q34118205-FCAF1A99-994F-4E8D-905A-3784B4336D10Q34648134-EDB6971A-EAA0-4A51-A77E-B34FC7C9CE0BQ34648461-223ED4A5-A9DC-4C1E-A842-6CF7A61D29A1Q34717075-5B01E130-8F66-4B6B-958F-B45B10B58034Q36159670-8BE0AB4D-028A-4D4D-956D-2B50CC6B5EACQ36286082-04B35420-E259-4FCF-A370-09F0EC2D2C06Q36484103-BAC2C7D7-D987-44E2-B59B-5FFE3F9B596BQ37547173-33DE2B8D-6E7B-43AD-A08A-D9297EA56027Q37956499-63D48C61-FB60-4451-9674-4AEDEFB7D152Q38610343-0CC5E6BF-6819-46F2-A77C-70B9749EADD1Q39034871-55AF6E35-17F1-47FF-827A-0B3FCD5C67A6Q39249793-4BE1070B-23FB-4489-9E52-924F039648A3Q40048134-FF5FF5C7-7EEB-4C0A-8EE8-8416F222FCC3Q40220475-A6EC6B5E-73E9-4C55-93A2-5E69BA0E9EDBQ40508331-25A6C0EF-D02F-479C-AA8E-7266EE437C24Q44169686-87A6EA5B-7CC6-4B19-B55A-B610D3CA0A8FQ52310640-1DFE2256-EBBD-4111-AFA1-18C6B6D21620Q57261369-92F5570F-E13B-4BCD-8155-9E041F6282D3Q66679572-BCC0FDD8-56BF-482A-864B-01F065430E1CQ93115377-F96DDB93-65BB-4404-BAFF-549F13F81D28
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amy L Hartman
@nl
Amy L Hartman
@sl
Amy L. Hartman
@en
Amy L. Hartman
@es
type
label
Amy L Hartman
@nl
Amy L Hartman
@sl
Amy L. Hartman
@en
Amy L. Hartman
@es
prefLabel
Amy L Hartman
@nl
Amy L Hartman
@sl
Amy L. Hartman
@en
Amy L. Hartman
@es
P106
P1153
7102651927
P1233
P1960
omptWooAAAAJ
P21
P31
P496
0000-0002-0857-2973